|
1
|
Brash AR: Arachidonic acid as a bioactive
molecule. J Clin Invest. 107:1339–1345. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roman RJ: P-450 metabolites of arachidonic
acid in the control of cardiovascular function. Physiol Rev.
82:131–185. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shen HC: Soluble epoxide hydrolase
inhibitors: A patent review. Expert Opin Ther Pat. 20:941–956.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miyata N and Roman RJ: Role of
20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. J
Smooth Muscle Res. 41:175–193. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Campbell WB: New role for
epoxyeicosatrienoic acids as anti-inflammatory mediators. Trends
Pharmacol Sci. 21:125–127. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen JK, Capdevila J and Harris RC:
Cytochrome p450 epoxygenase metabolism of arachidonic acid inhibits
apoptosis. Mol Cell Biol. 21:6322–6331. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y, Oltman CL, Lu T, Lee HC,
Dellsperger KC and VanRollins M: EET homologs potently dilate
coronary microvessels and activate BK(Ca) channels. Am J Physiol
Heart Circ Physiol. 280:H2430–H2440. 2001.PubMed/NCBI
|
|
8
|
Liu X, Wu J, Liu H, Lai G and Zhao Y:
Disturbed ratio of renal 20-HETE/EETs is involved in
androgen-induced hypertension in cytochrome P450 4F2 transgenic
mice. Gene. 505:352–359. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Certíková Chábová V, Kramer HJ, Vanecková
I, Thumová M, Skaroupková P, Tesar V, Falck JR, Imig JD and
Cervenka L: The roles of intrarenal 20-hydroxyeicosatetraenoic and
epoxyeicosatrienoic acids in the regulation of renal function in
hypertensive Ren-2 transgenic rats. Kidney Blood Press Res.
30:335–346. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Eid S, Maalouf R, Jaffa AA, Nassif J,
Hamdy A, Rashid A, Ziyadeh FN and Eid AA: 20-HETE and EETs in
diabetic nephropathy: A novel mechanistic pathway. PLoS One.
8:e700292013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu Z, Xu F, Huse LM, Morisseau C, Draper
AJ, Newman JW, Parker C, Graham L, Engler MM, Hammock BD, et al:
Soluble epoxide hydrolase regulates hydrolysis of vasoactive
epoxyeicosatrienoic acids. Circ Res. 87:992–998. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu X, Zhao Y, Wang L, Yang X, Zheng Z,
Zhang Y, Chen F and Liu H: Overexpression of cytochrome P450 4F2 in
mice increases 20-hydroxyeicosatetraenoic acid production and
arterial blood pressure. Kidney Int. 75:1288–1296. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals, . Guide for the Care and Use of Laboratory Animals. 8th.
National Academies Press; Washington (DC), USA: 2011, PubMed/NCBI
|
|
14
|
Liu Y, Dang H, Li D, Pang W, Hammock BD
and Zhu Y: Inhibition of soluble epoxide hydrolase attenuates
high-fat-diet-induced hepatic steatosis by reduced systemic
inflammatory status in mice. PLoS One. 7:e391652012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lai G, Wu J, Liu X and Zhao Y: 20-HETE
induces hyperglycemia through the cAMP/PKA-PhK-GP pathway. Mol
Endocrinol. 26:1907–1916. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Imig JD and Hammock BD: Soluble epoxide
hydrolase as a therapeutic target for cardiovascular diseases. Nat
Rev Drug Discov. 8:794–805. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Singh H and Schwartzman ML: Renal vascular
cytochrome P450-derived eicosanoids in androgen-induced
hypertension. Pharmacol Rep. 60:29–37. 2008.PubMed/NCBI
|
|
18
|
Imig JD, Zhao X, Capdevila JH, Morisseau C
and Hammock BD: Soluble epoxide hydrolase inhibition lowers
arterial blood pressure in angiotensin II hypertension.
Hypertension. 39:690–694. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kopkan L, Husková Z, Sporková A, Varcabová
Š, Honetschlägerová Z, Hwang SH, Tsai HJ, Hammock BD, Imig JD,
Kramer HJ, et al: Soluble epoxide hydrolase inhibition exhibits
antihypertensive actions independently of nitric oxide in mice with
renovascular hypertension. Kidney Blood Press Res. 35:595–607.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao X, Yamamoto T, Newman JW, Kim IH,
Watanabe T, Hammock BD, Stewart J, Pollock JS, Pollock DM and Imig
JD: Soluble epoxide hydrolase inhibition protects the kidney from
hypertension-induced damage. J Am Soc Nephrol. 15:1244–1253.
2004.PubMed/NCBI
|
|
21
|
Ishizuka T, Cheng J, Singh H, Vitto MD,
Manthati VL, Falck JR and Laniado-Schwartzman M:
20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB
activation and the production of inflammatory cytokines in human
endothelial cells. J Pharmacol Exp Ther. 324:103–110. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo P, Chang HH, Zhou Y, Zhang S, Hwang
SH, Morisseau C, Wang CY, Inscho EW, Hammock BD and Wang MH:
Inhibition or deletion of soluble epoxide hydrolase prevents
hyperglycemia, promotes insulin secretion, and reduces islet
apoptosis. J Pharmacol Exp Ther. 334:430–438. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fidelis P, Wilson L, Thomas K, Villalobos
M and Oyekan AO: Renal function and vasomotor activity in mice
lacking the Cyp4a14 gene. Exp Biol Med (Maywood). 235:1365–1374.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Athirakul K, Bradbury JA, Graves JP,
DeGraff LM, Ma J, Zhao Y, Couse JF, Quigley R, Harder DR, Zhao X,
et al: Increased blood pressure in mice lacking cytochrome P450
2J5. FASEB J. 22:4096–4108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luo G, Zeldin DC, Blaisdell JA, Hodgson E
and Goldstein JA: Cloning and expression of murine CYP2Cs and their
ability to metabolize arachidonic acid. Arch Biochem Biophys.
357:45–57. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pratt PF, Falck JR, Reddy KM, Kurian JB
and Campbell WB: 20-HETE relaxes bovine coronary arteries through
the release of prostacyclin. Hypertension. 31:237–241. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Oyekan AO: Differential effects of
20-hydroxyeicosatetraenoic acid on intrarenal blood flow in the
rat. J Pharmacol Exp Ther. 313:1289–1295. 2005. View Article : Google Scholar : PubMed/NCBI
|
